OMEROS CORP

OMER NASDAQ

savepiginvest

Biologics License Application for Narsoplimab in HSCT-TMA Accepted for Priority Review by U.S. FDA -- FDA sets PDUFA date of July 17, 2021 --

TradingMula

Swing long target $18.50

CryptoFundManager

Omeros Submits its Biologics License Application to U.S. FDA for Narsoplimab in HSCT-TMA for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. (businesswire.com), Nov 18 Omeros (OMER) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.51. This quarterly report represents...

oozyi

omer

oozyi

omer

Shahkulu

$OMER - Renko (90 ATR, 90 min) we use stoch/mfi/rsi together with default settings. this is a very choppy chart to analyze if you chart it normally. renko allows us to filter that choppiness. Stoch oversold, MFI on trigger zone, RSI moving to oversold zone. we must wait for the price to reverse to neckline before we make entry ( > $12.50 ) also this may be a...

STOCKRETURN

Looks like I found support

LeLaf

Higher price rejection after gap up May try to fill it in the next few days, If confirmed PT1 = 19,61 PT2 = 14,48 for gap fill

AlenCiken

Recovery and Survival of All Patients in Study Evaluating Narsoplimab for Treatment of COVID-19-Associated Acute Respiratory Distress Syndrome -- All six patients, requiring mechanical ventilation prior to treatment, recovered, survived and were discharged from the hospital -- Narsoplimab treatment was associated with rapid and sustained improvement across all...

Bullishcharts

Major downtrends broken after earnings beat. Possible entry level above resistance $15.05 Target price $17.17 Stop loss $14.30 Company profile Omeros Corp. operates as a biopharmaceutical company. It engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. It also offers orphan indications...

honorbear

triple bottom. adx going up... next stop in 14.20 added to trading postion. 4k.

KAS109

Watching for a break above $14.75. nice base consolidation here. Former runner. Ascending wedge pattern. 10, 20 and 50 EMA forming a nice floor for a stop loss. See if it holds $14 or not. No position yet. Risk: biotechs normally I avoid, but this has a nice pattern. Also on guard for any overall market weakness which will probably negate this as a potential...

jhuntman

Omer long nice triangle setup Looking to get in before move up :)

jhuntman

Price Action for Omer Watching for a liquidity grab and volume increase to complete a sloppy inverse HS on Daily charts

jhuntman

Watching volume

joseramonperezq

good move above prior horizontal resistance, expecting a retest of the new support to go long with a better risk reward ratio.

savepiginvest

Omeros has been consolidating after breaking out of its long downtrend, but looks set to make a new attempt to move upwards, coinciding with a strong move in the $BB etf. Needs volume of trade to confirm this move, while investors are waiting for a list of catalysts to trigger interest.

savepiginvest

Omeros has been through a rough patch with shortsellers in full control, coming down from a swinging high last year. With recent good news on several fronts, $OMER is trading well above longtrend, and looking to fully confirm breakout.